Vishwadeep Shelke

Pilani, RJ 333031, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Renoprotective Effects of Phloretin and TUDCA via Simultaneous Inhibition of TLR4/MyD88/NF-κB and BiP/PERK/CHOP Pathways in AKI Under Diabetic Condition.

Renoprotective Effects of Phloretin and TUDCA via Simultaneous Inhibition of TLR4/MyD88/NF-κB and BiP/PERK/CHOP Pathways in AKI Under Diabetic Condition.

Journal: Applied biochemistry and biotechnology

Published: June 19, 2025

Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress.

Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress.

Journal: Cell biology international

Published: November 19, 2024

ULK1 as a therapeutic target in kidney diseases: Current perspective.

ULK1 as a therapeutic target in kidney diseases: Current perspective.

Journal: Expert opinion on therapeutic targets

Published: November 11, 2024

Management of inflammaging in kidney diseases: focusing on the current investigational drugs.

Management of inflammaging in kidney diseases: focusing on the current investigational drugs.

Journal: Expert opinion on investigational drugs

Published: October 15, 2024

Acyl-CoA Synthetase Long-Chain Isoenzymes in Kidney Diseases: Mechanistic Insights and Therapeutic Implications.

Acyl-CoA Synthetase Long-Chain Isoenzymes in Kidney Diseases: Mechanistic Insights and Therapeutic Implications.

Journal: Cell biochemistry and function

Published: July 14, 2024

Apelinergic system in acute kidney injury: Mechanistic insights and therapeutic potential.

Apelinergic system in acute kidney injury: Mechanistic insights and therapeutic potential.

Journal: Life sciences

Published: June 10, 2024

Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management.

Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management.

Journal: Fundamental & clinical pharmacology

Published: April 02, 2024

Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges.

Natriuretic peptide system in hypertension: Current understandings of its regulation, targeted therapies and future challenges.

Journal: European journal of pharmacology

Published: March 19, 2024

Immunosuppressants against acute kidney injury: what to prefer or to avoid?

Immunosuppressants against acute kidney injury: what to prefer or to avoid?

Journal: Immunopharmacology and immunotoxicology

Published: March 13, 2024

Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity.

Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity.

Journal: Free radical research

Published: February 07, 2024

Esculetin and Phloretin Combination Mitigates Acute Kidney Injury-Diabetes Comorbidity via Regulating Mitophagy and Inflammation: A Dual-Pronged Approach.

Esculetin and Phloretin Combination Mitigates Acute Kidney Injury-Diabetes Comorbidity via Regulating Mitophagy and Inflammation: A Dual-Pronged Approach.

Journal: Phytotherapy research : PTR

Published: January 12, 2024

Phloretin: a comprehensive review of its potential against diabetes and associated complications.

Phloretin: a comprehensive review of its potential against diabetes and associated complications.

Journal: The Journal of pharmacy and pharmacology

Published: December 11, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026